Sagar Lonial

CIK: 0001816609

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TGTX

TG THERAPEUTICS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

TGTX
TG THERAPEUTICS, INC.
Jun 11, 2026
Award(A)
Stock Tracking Unit
Direct
8.3K shares-
TGTX
TG THERAPEUTICS, INC.
Sep 11, 2025
Sale(S)
Direct
20.9K shares at avg. $32.24$672K
TGTX
TG THERAPEUTICS, INC.
Jun 12, 2025
Award(A)
Direct
14.7K shares-
TGTX
TG THERAPEUTICS, INC.
Nov 11, 2024
Sale(S)
Direct
5K shares at avg. $30.44$152K

		Type	Shares	Price		Ownership
Jun 11, 2026	TGTX TG THERAPEUTICS, INC.	Award(A) Stock Tracking Unit	8,325	-	-	Direct
Sep 11, 2025	TGTX TG THERAPEUTICS, INC.	Sale(S)	20,852	$32.24	$672,268	Direct
Jun 12, 2025	TGTX TG THERAPEUTICS, INC.	Award(A)	14,718	-	-	Direct
Nov 11, 2024	TGTX TG THERAPEUTICS, INC.	Sale(S)	5,000	$30.44	$152,200	Direct

1-4 of 4 transactions

About Lonial Sagar

Lonial Sagar (SEC CIK 0001816609) files insider reports with the SEC as Director of TG THERAPEUTICS, INC. (TGTX).

Signal8 holds 4 ownership filings by Lonial Sagar, all Form 4s, filed between Nov 12, 2024 and Jun 15, 2026. Those filings report 4 transactions, from Nov 11, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Lonial Sagar's filings is in MORRISVILLE, NC.

Recent filings by Lonial Sagar

Jun 11, 2026: Grant or award of TGTX derivative securities (Form 4, code A).
Sep 11, 2025: Open-market sale of TGTX shares (Form 4, code S).
Jun 12, 2025: Grant or award of TGTX shares (Form 4, code A).
Nov 11, 2024: Open-market sale of TGTX shares (Form 4, code S).

Other insiders filing for TG THERAPEUTICS, INC. (TGTX)

How to read Form 4 transaction codes